Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

FDA approves addition of overall survival data to carfilzomib label

FDA approves addition of overall survival data to carfilzomib label

Modular gene enhancer promotes leukaemia and regulates effectiveness of chemotherapy

Modular gene enhancer promotes leukaemia and regulates effectiveness of chemotherapy

Patients with blood cancer precursor at risk of developing cancer even after 30 years

Patients with blood cancer precursor at risk of developing cancer even after 30 years

By altering bone marrow, training can prepare innate immune system for future challenges

By altering bone marrow, training can prepare innate immune system for future challenges

Improved blood stabilisation should expand use of circulating tumour cell profiling

Improved blood stabilisation should expand use of circulating tumour cell profiling

Some leukaemia patients may be missing out on new treatments

Some leukaemia patients may be missing out on new treatments

Throwing molecular wrench into gene control machine leads to 'melting away' of leukaemia

Throwing molecular wrench into gene control machine leads to 'melting away' of leukaemia

FDA approves denosumab for the prevention of skeletal events In multiple myeloma patients

FDA approves denosumab for the prevention of skeletal events In multiple myeloma patients

Tumour suppressor gene variants identified as cancer 'double whammy' for leukaemia patients

Tumour suppressor gene variants identified as cancer 'double whammy' for leukaemia patients

Researchers detect a loophole in chronic lymphocytic leukaemia treatment

Researchers detect a loophole in chronic lymphocytic leukaemia treatment

More from ecancer